<p>Baseline characteristics of 76 patients who unexpectedly diagnosed with PTB.</p
<p>Baseline characteristics of the 72 PPGL patients according to the occurrence of metastasis.</p
<p>Baseline characteristics of patients, risk factors, clinical severity and diagnosis.</p
<p>Baseline characteristics of 87 prostate cancer and 24 BPH patients included in the study.</p
Baseline characteristics of 49 patients with a first TMA event by their neurological status.</p
<p>Demographic and clinical characteristics of 650 patients with presumed PTB.</p
<p>Baseline characteristics of the patients and established etiological diagnosis.</p
<p>Baseline characteristics of patients in the included Randomized Clinical Trials.</p
<p>Baseline demographic and clinical characteristics of the study population (N = 342 patients).</p
<p>Baseline characteristics of the 1368 study patients and 150 healthy persons.</p
<p>Baseline characteristics of patients who were treated with statin and those who were not.</p
Baseline clinical characteristics and laboratory data of eligible patients in pre- and post-PBPM.</p
Baseline characteristics of the patients in the per-protocol population (n = 54).</p
<p>Baseline characteristics of 416 pulmonary TB patients according to regimen.</p
Baseline clinical characteristics of patients who were followed up for 6 months.</p
<p>Baseline demographic and clinicopathologic characteristics of the 849,088 study patients.</p
<p>Baseline characteristics of the 72 PPGL patients according to the occurrence of metastasis.</p
<p>Baseline characteristics of patients, risk factors, clinical severity and diagnosis.</p
<p>Baseline characteristics of 87 prostate cancer and 24 BPH patients included in the study.</p
Baseline characteristics of 49 patients with a first TMA event by their neurological status.</p
<p>Demographic and clinical characteristics of 650 patients with presumed PTB.</p
<p>Baseline characteristics of the patients and established etiological diagnosis.</p
<p>Baseline characteristics of patients in the included Randomized Clinical Trials.</p
<p>Baseline demographic and clinical characteristics of the study population (N = 342 patients).</p
<p>Baseline characteristics of the 1368 study patients and 150 healthy persons.</p
<p>Baseline characteristics of patients who were treated with statin and those who were not.</p
Baseline clinical characteristics and laboratory data of eligible patients in pre- and post-PBPM.</p
Baseline characteristics of the patients in the per-protocol population (n = 54).</p
<p>Baseline characteristics of 416 pulmonary TB patients according to regimen.</p
Baseline clinical characteristics of patients who were followed up for 6 months.</p
<p>Baseline demographic and clinicopathologic characteristics of the 849,088 study patients.</p
<p>Baseline characteristics of the 72 PPGL patients according to the occurrence of metastasis.</p
<p>Baseline characteristics of patients, risk factors, clinical severity and diagnosis.</p
<p>Baseline characteristics of 87 prostate cancer and 24 BPH patients included in the study.</p
DOI
Add to ORKG